Skip to main content

Table 2 The correlation between the 24 hub genes and clinical characteristics

From: A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells

Gene

Cor(P-value)

Age

Gender

Grade

Stage(I/II/III/IV)

T stage

CCR7

0.994(0.323)

0.789(0.435)

1.741(0.086)

2.263(0.026)

2.223(0.029)

CXCL1

0.52(0.604)

-0.359(0.720)

-1.719(0.093)

-1.153(0.257)

-1.13(0.267)

CXCR3

0.952(0.343)

0.352(0.726)

-0.322(0.749)

0.476(0.636)

0.408(0.685)

CXCL5

0.92(0.360)

-0.986(0.326)

-1.501(0.141)

-1.339(0.190)

-1.351(0.187)

TNFRSF11B

0.172(0.864)

-0.79(0.431)

-0.507(0.614)

-0.297(0.769)

-0.341(0.735)

CD247

0.634(0.527)

1.032(0.308)

-0.099(0.921)

0.808(0.422)

0.713(0.478)

S100A9

0.588(0.558)

-0.251(0.803)

-0.194(0.846)

0.393(0.695)

0.338(0.736)

LTBP1

-0.675(0.502)

1.013(0.316)

-0.917(0.363)

-2.286(0.029)

-1.666(0.104)

CD79B

1.312(0.193)

0.422(0.675)

0.53(0.597)

2.251(0.027)

2.197(0.031)